Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/2
112
about 7.1 years
18–90
3 sites in MO, NE, PA
What this study is about
This trial is testing a new treatment called Lead-212 PSV359 in people with solid tumors. The goal is to determine the safety and effectiveness of this treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [203Pb]Pb-PSV359
- 2.Take [212Pb]Pb-PSV359
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Determination of safety and tolerability of [203Pb]Pb-PSV359, Determination of safety and tolerability of [212Pb]Pb-PSV359
Secondary: Determination of duration of response following treatment with [212Pb]Pb-PSV359, Determination of pharmacokinetic properties of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359, Determination of progression free survival following treatment with [212Pb]Pb-PSV359
Oncology